title: Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck.
authors.forename: M
authors.initials: M
authors.lastname: Degardin
authors.forename: P
authors.initials: P
authors.lastname: Cappelaere
authors.forename: I
authors.initials: I
authors.lastname: Krakowski
authors.forename: P
authors.initials: P
authors.lastname: Fargeot
authors.forename: D
authors.initials: D
authors.lastname: Cupissol
authors.forename: S
authors.initials: S
authors.lastname: Brienza
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D000077150:Oxaliplatin
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin